IBDEI0DW ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6384,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,6385,0)
 ;;=N52.32^^30^392^40
 ;;^UTILITY(U,$J,358.3,6385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6385,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,6385,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,6385,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,6386,0)
 ;;=N52.31^^30^392^41
 ;;^UTILITY(U,$J,358.3,6386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6386,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,6386,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,6386,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,6387,0)
 ;;=N52.2^^30^392^47
 ;;^UTILITY(U,$J,358.3,6387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6387,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,6387,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,6387,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,6388,0)
 ;;=N52.03^^30^392^38
 ;;^UTILITY(U,$J,358.3,6388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6388,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,6388,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,6388,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,6389,0)
 ;;=N52.02^^30^392^39
 ;;^UTILITY(U,$J,358.3,6389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6389,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,6389,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,6389,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,6390,0)
 ;;=N52.1^^30^392^46
 ;;^UTILITY(U,$J,358.3,6390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6390,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,6390,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,6390,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,6391,0)
 ;;=N52.01^^30^392^45
 ;;^UTILITY(U,$J,358.3,6391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6391,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,6391,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,6391,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,6392,0)
 ;;=N95.2^^30^392^87
 ;;^UTILITY(U,$J,358.3,6392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6392,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,6392,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,6392,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,6393,0)
 ;;=R30.9^^30^392^71
 ;;^UTILITY(U,$J,358.3,6393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6393,1,3,0)
 ;;=3^Micturition Painful,Unspec
 ;;^UTILITY(U,$J,358.3,6393,1,4,0)
 ;;=4^R30.9
 ;;^UTILITY(U,$J,358.3,6393,2)
 ;;=^5019324
 ;;^UTILITY(U,$J,358.3,6394,0)
 ;;=R30.0^^30^392^30
 ;;^UTILITY(U,$J,358.3,6394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6394,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,6394,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,6394,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,6395,0)
 ;;=R33.9^^30^392^111
 ;;^UTILITY(U,$J,358.3,6395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6395,1,3,0)
 ;;=3^Urine Retention,Unspec
 ;;^UTILITY(U,$J,358.3,6395,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,6395,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,6396,0)
 ;;=R32.^^30^392^109
 ;;^UTILITY(U,$J,358.3,6396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6396,1,3,0)
 ;;=3^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,6396,1,4,0)
 ;;=4^R32.
 ;;^UTILITY(U,$J,358.3,6396,2)
 ;;=^5019329
 ;;^UTILITY(U,$J,358.3,6397,0)
 ;;=N39.41^^30^392^107
 ;;^UTILITY(U,$J,358.3,6397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6397,1,3,0)
 ;;=3^Urge Incontinence
 ;;^UTILITY(U,$J,358.3,6397,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,6397,2)
 ;;=^5015680
